Andrx, Schering Settle Claritin-D Patent Dispute
Andrx will receive a license to a patent for the drug from Schering-Plough, the company said. Andrx said that the lawsuit would be dismissed, but did not disclose financial terms of the settlement.
Andrx's generic Claritin-D 24 is marketed by Perrigo Company as an over-the-counter product used for the relief of symptoms of seasonal allergic rhinitis, commonly known as hay fever, the company...
To view the full article, register now.